Intrapleural Fibrinolytics Use in Children with Pleural Empyema: Safe and Effective
Respiration · 19.06.2026 · 1-4
DOI: 10.1159/000553095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respiration, online erschienen am 19.06.2026. Verfasst von Carmen C M de Jong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Pulmonology, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, The Netherlands, carmen.dejong@insel.ch. Die Arbeit nennt 12 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
We assessed the number of children with pleural empyema in which video-assisted thoracoscopy (VATS) could be avoided in a center where standard therapy is drainage using a chest drain with/without intrapleural fibrinolytics.
Methods
We included all children referred for chest drainage of a pleural effusion to Radboud University Medical Center between January 2022 and April 2023. Children were referred in case of pneumonia with respiratory distress and suspected pleural effusion on the chest X-ray or an effusion size of >20 mm in the chest ultrasound, indicating the need for chest drainage or VATS. We analyzed symptoms, test results, and treatment.
Results
Thirty-two children aged 0–16 years were referred for treatment of pleural effusion. Most children presented with fever, cough, and dyspnea (72%). Four children presented with abdominal pain (13%), which led to 2 appendectomies prior to referral. In 11 (33%) children, an invasive group A streptococcus was cultured from the pleural fluid. All patients were treated with antibiotics. One patient received VATS primarily. 27 (84%) patients received a chest drain, and 4 patients continued conservative treatment. 14 (52%) of the 27 children with a chest drain were treated with intrapleural fibrinolytics (alteplase or urokinase) because of persistent pleural effusion on ultrasound despite chest drainage. No side effects were observed. Two patients received VATS secondary to chest drainage without receiving prior intrapleural fibrinolytics.
Conclusion
Intrapleural fibrinolytic treatment appeared safe and could avoid VATS in children with poor drainage, and is therefore a useful minimal invasive treatment in children with pleural empyema.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Pulmonology, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, The Netherlands, carmen.dejong@insel.ch.
- Division of Paediatric Respiratory Medicine and Allergology, Department of Paediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland, carmen.dejong@insel.ch.
- Department of Pediatric Pulmonology, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, The Netherlands.
Zitieren
APA
de Jong, C. C. M., Heijting, I. E., Merkus, P. J. F. M., Roukema, J., van den Wijngaart, L. S., & Pourier, M. S. (2026). Intrapleural Fibrinolytics Use in Children with Pleural Empyema: Safe and Effective. Respiration, 1-4. https://doi.org/10.1159/000553095
Vancouver
de Jong CCM, Heijting IE, Merkus PJFM, Roukema J, van den Wijngaart LS, Pourier MS. Intrapleural Fibrinolytics Use in Children with Pleural Empyema: Safe and Effective. Respiration. 2026:1-4. doi:10.1159/000553095
BibTeX
@article{deJong2026,
author = {de Jong, Carmen C M and Heijting, Ilia E and Merkus, Peter J F M and Roukema, Jolt and van den Wijngaart, Lara S and Pourier, Milanthy S},
title = {Intrapleural Fibrinolytics Use in Children with Pleural Empyema: Safe and Effective},
journal = {Respiration},
year = {2026},
pages = {1--4},
doi = {10.1159/000553095}
}
EUVIMED